Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Maintains Neutral on Zymeworks BC, Raises Price Target to $10

HC Wainwright & Co. analyst Robert Burns maintains Zymeworks BC (NYSE:ZYME) with a Neutral and raises the price target from $8 to $10.
byBenzinga Newsdesk
November 21, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Robert Burns maintains Zymeworks BC (NYSE:ZYME) with a Neutral and raises the price target from $8 to $10.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0